BCMA Antibody / CD269 / TNFRSF17 |
|||
RQ4272 | NSJ Bioreagents | 100 ug | 419 EUR |
BCMA Antibody / CD269 / TNFRSF17 |
|||
RQ4364 | NSJ Bioreagents | 100 ug | 419 EUR |
BCMA Antibody / CD269 / TNFRSF17 |
|||
RQ4365 | NSJ Bioreagents | 100 ug | 419 EUR |
BCMA Antibody / Cd269 / Tnfrsf17 |
|||
RQ5844 | NSJ Bioreagents | 100 ug | 419 EUR |
BCMA Antibody / CD269 / TNFRSF17 |
|||
V3814-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: The B cell maturation protein (BCMA) is a type I integral membrane protein that belongs to the tumor necrosis factor receptor (TNF-R) superfamily. It is expressed as a 184 amino acid peptide that is expressed only in mature B-lymphocytes and is located on the cis part of the Golgi apparatus. BCMA shares significant homology with TACI (transmembrane activator) within the cysteine-rich domain. TACI has been shown to bind CAML, which induces activation of NFAT (nuclear factor of activated T cells). Both BCMA and TACI have been shown to bind APRIL and TALL-1, which stimulate B cell proliferation in conjunction with other B-cell activators. When overexpressed, TALL-1 stimulates the development of systemic lupus erythaematosus (SLE). |
|||
BCMA Antibody / CD269 / TNFRSF17 |
|||
V3814-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: The B cell maturation protein (BCMA) is a type I integral membrane protein that belongs to the tumor necrosis factor receptor (TNF-R) superfamily. It is expressed as a 184 amino acid peptide that is expressed only in mature B-lymphocytes and is located on the cis part of the Golgi apparatus. BCMA shares significant homology with TACI (transmembrane activator) within the cysteine-rich domain. TACI has been shown to bind CAML, which induces activation of NFAT (nuclear factor of activated T cells). Both BCMA and TACI have been shown to bind APRIL and TALL-1, which stimulate B cell proliferation in conjunction with other B-cell activators. When overexpressed, TALL-1 stimulates the development of systemic lupus erythaematosus (SLE). |
|||
CD269 Blocking Peptide |
|||
20-abx161058 | Abbexa |
|
|
Recombinant Human TNFRSF17/BCMA/CD269 Protein |
|||
RP00155 | Abclonal | 5 μg | 163.2 EUR |
Tumor Necrosis Factor Receptor Superfamily Member 17 (CD269) Antibody |
|||
20-abx121058 | Abbexa |
|
|
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC942366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC942366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNCA2366-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), APC conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC552366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC552366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC612366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC612366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNCP2366-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNCR2366-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC402366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC402366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC432366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC432366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC052366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC052366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC812366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC812366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC802366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC802366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNCH2366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNCH2366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNUB2366-100 | Biotium | 100uL | 316.8 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Concentration: 0.2mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNUB2366-50 | Biotium | 50uL | 486 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), 1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNUB2366-500 | Biotium | 500uL | 615.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), Concentration: 0.2mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC042366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC042366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC682366-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366) Antibody |
|||
BNC682366-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF568 conjugate, Concentration: 0.1mg/mL |